1.	Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: 05-122, MSKCC-05122, NCT00445965
2.	Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2005-0883, NCT00432445
3.	Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-03112, 050909, U01CA132194, CINJ-050801, 050801, 0220080281, NCT00813423
4.	Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000663520, COG-ADVL0911, ADVL0911, NCT01048892
5.	A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma Phase: No phase specified Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 08-885, no grant, NCT00857519
6.	Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma Phase: No phase specified Type: Treatment Status: Active Age: 10 and under Sponsor: Other Protocol IDs: RELRB1, NCT00980551
7.	Auto Transplant for High Risk or Relapsed Solid Tumor Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569